| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
152,980,000 |
| Market
Cap: |
2.65(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$12.12 - $24.64 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Certara is a holding company. Through its subsidiaries, Co. delivers software products and technology-enabled services to customers to realize the benefits of biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions and market access. Co.'s End-to-End Platform provides software and technology-enabled services. Co. deploys its software to customers on public and private cloud networks, on-premises, and in data centers. Co.'s technology-enabled, biosimulation services help customers who do not have staff capability or availability to gain the benefits of biosimulation. Co. also provides related, technology-enabled services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,000 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$79,058 |
$821,458 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
2 |
4 |
| Total Shares Sold |
31,427 |
37,427 |
112,755 |
38,359,838 |
| Total Sell Value |
$550,001 |
$658,001 |
$1,921,662 |
$597,865,261 |
| Total People Sold |
2 |
2 |
3 |
6 |
| Total Sell Transactions |
5 |
6 |
9 |
23 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Traynor Richard M. |
SVP AND GENERAL COUNSEL |
• – – |
2021-06-24 |
4 |
AS |
$26.37 |
$131,850 |
D/D |
(5,000) |
353,287 |
|
61% |
|
| Feehery William F |
CHIEF EXECUTIVE OFFICER |
• • – |
2021-06-23 |
4 |
AS |
$26.53 |
$1,989,878 |
D/D |
(75,000) |
3,238,051 |
|
57% |
|
| Schemick Michael Andrew |
CHIEF FINANCIAL OFFICER |
• – – |
2021-06-22 |
4 |
AS |
$26.94 |
$1,795,982 |
D/D |
(66,666) |
830,177 |
|
52% |
|
| Edge Justin |
PRES., REGULATORY & ACCESS |
• – – |
2021-06-16 |
4 |
AS |
$27.02 |
$135,075 |
D/D |
(5,000) |
447,090 |
|
42% |
|
| Aspbury Robert |
PRESIDENT, SIMCYP |
• – – |
2021-06-14 |
4 |
AS |
$27.49 |
$533,906 |
D/D |
(19,354) |
372,444 |
|
41% |
|
| Rayner Craig R. |
PRESIDENT, INTEGRATED DRUG DEV |
• – – |
2021-06-11 |
4 |
AS |
$25.70 |
$2,800,164 |
D/D |
(108,924) |
370,472 |
|
41% |
|
| Slaine Mason P |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,059 |
2,739,614 |
|
- |
|
| Walsh Matthew M |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,059 |
179,960 |
|
- |
|
| Mccoy Sherilyn S |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,059 |
621,143 |
|
- |
|
| Cashman James E III |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,059 |
483,782 |
|
- |
|
| Rayner Craig R. |
PRESIDENT, INTEGRATED DRUG DEV |
• – – |
2021-04-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
38,462 |
479,396 |
|
- |
|
| Rayner Craig R. |
See Remarks |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,810 |
464,744 |
|
- |
|
| Choe Jieun W. |
See Remarks |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,315 |
342,991 |
|
- |
|
| Traynor Richard M. |
SVP and General Counsel |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,484 |
358,287 |
|
- |
|
| Schemick Michael Andrew |
Chief Financial Officer |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
34,799 |
896,843 |
|
- |
|
| Edge Justin |
See Remarks |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,810 |
452,090 |
|
- |
|
| Feehery William F |
Chief Executive Officer |
• • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
91,575 |
3,313,051 |
|
- |
|
| Dickinson Judith |
See Remarks |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,905 |
173,564 |
|
- |
|
| Aspbury Robert |
President, Simcyp |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,315 |
391,798 |
|
- |
|
| Pedersen Leif E |
President, Software |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,810 |
279,928 |
|
- |
|
| Eqt Fund Management S.a R.l. |
10% Owner |
– – • |
2021-03-29 |
4 |
S |
$24.13 |
$209,263,893 |
I/I |
(8,674,151) |
66,223,861 |
|
-12% |
|
| Cashman James E III |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$460,000 |
D/D |
20,000 |
476,723 |
2.39 |
-6% |
|
| Mclean Stephen M. |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$506,000 |
D/D |
22,000 |
22,000 |
2.39 |
-6% |
|
| Walsh Matthew M |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$115,000 |
D/D |
5,000 |
172,901 |
2.39 |
-6% |
|
| Traynor Richard M. |
SVP and General Counsel |
• – – |
2020-12-15 |
4 |
B |
$23.00 |
$5,635 |
D/D |
245 |
341,803 |
2.74 |
-6% |
|
71 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.19 (1.11%) 
